Pharmabiz

US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay

US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay: San Diego Tuesday, November 4, 2025, 18:00 Hrs ...
Pharmabiz

Actimed Therapeutics receives Japanese patent for new composition of matter patent for S-pindolol benzoate

Actimed Therapeutics receives Japanese patent for new composition of matter patent for S-pindolol benzoate: London, UK Tuesday, November 4, 2025, 16:00 Hrs [IST] Actimed Therapeut ...
Pharmabiz

Alkem Foundation and IIT Bombay collaborate to set up research centre for immuno-therapeutics and regenerative medicines

Our Bureau, Mumbai Tuesday, November 4, 2025, 16:30 Hrs [IST] ...
Pharmabiz

Integrating family planning and maternity services reduces global maternal mortality

Integrating family planning and maternity services reduces global maternal mortality: Geneva Tuesday, November 4, 2025, 17:00 Hrs [IST] A landmark study published in The Lancet Gl ...
Pharmabiz

MedGenome invests into Gujarat-based diagnostics chain Green Cross to expand genomics offerings across India

MedGenome invests into Gujarat-based diagnostics chain Green Cross to expand genomics offerings across India: Our Bureau, Bengaluru Tuesday, November 4, 2025, 14:15 Hrs [IST] MedG ...
Pharmabiz

UK MHRA calls on public to report side effects and suspected fakes during #MedSafetyWeek

UK MHRA calls on public to report side effects and suspected fakes during #MedSafetyWeek: United Kingdom Tuesday, November 4, 2025, 15:00 Hrs [IST] The Medicines and Healthcare pr ...
Pharmabiz

University of Glasgow scientists use AI to study the intricate language of biomolecules

University of Glasgow scientists use AI to study the intricate language of biomolecules: Our Bureau, Bengaluru Tuesday, November 4, 2025, 14:15 Hrs [IST] University of Glasgow sci ...
Pharmabiz

Merck Foundation launches $22 million initiative to improve cardiovascular care in the US

Merck Foundation launches $22 million initiative to improve cardiovascular care in the US: Rahway, New Jersey Tuesday, November 4, 2025, 14:00 Hrs [IST] The Merck Foundation annou ...
Pharmabiz

Major change for rare disease treatments on way, signals MHRA

Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...
Pharmabiz

China NMPA grants breakthrough therapy designation to Akeso’s ivonescimab for first-line treatment of triple-negative breast cancer

Ivonescimab combined with chemotherapy for locally advanced or metastatic NSCLC resistant to EGFR-TKI therapy, which has now been approved for marketing in China and added to China’s National ...
Pharmabiz

CDSCO updates list of Class A non-sterile and non-measuring devices

CDSCO updates list of Class A non-sterile and non-measuring devices: Gireesh Babu, New Delhi Tuesday, November 4, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control Organisa ...
Pharmabiz

Roche’s phase III ALLEGORY study of Gazyva/Gazyvaro in adults with systemic lupus erythematosus meets its primary endpoint

Roche’s phase III ALLEGORY study of Gazyva/Gazyvaro in adults with systemic lupus erythematosus meets its primary endpoint: Basel Tuesday, November 4, 2025, 12:00 Hrs [IST] Roch ...